Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding Gastric Varices
Completed · Not applicable
Conditions studied: Gastric Bleeding, Cirrhosis
In brief
In unselected cirrhotic patients with bleeding gastric varices to compare the influence on mortality rate, duration of life, control of bleeding, quality of life, and economic costs of treatment of: portacaval shunt, endoscopic variceal sclerotherapy and/or variceal ligation.
Key facts
- Study ID
- NCT00820781
- Run by
- University of California, San Diego
- People needed
- 518
- Starts
- 1977-08-01
- Expected to finish
- 2003-04-01
- Last updated by the study team
- 2009-01-12
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients with upper gastrointestinal bleeding (blood in the upper gastrointestinal tract) of a magnitude that required 2 or more units of blood transfusion and entered the emergency room directly, or were referred from an area hospital, or developed bleeding while in the hospital, and were shown to have cirrhosis of the liver, and were shown by endoscopy to have bleeding gastric varices, absence of bleeding from esophageal varices, and absence of any other lesion that could reasonably account for the bleeding were included ("all comers").
You may not qualify if…
- None
Where it is running
- UCSD Medical Center — San Diego, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.